Glenn Braunstein

Glenn Braunstein is Pathway Genomics' new chief medical officer, where he will oversee the company’s pharmacogenomics testing menu.

Previously, Braunstein was VP of clinical innovation and director of the thyroid cancer program at Cedars-Sinai Medical Center, where he also chaired the department of medicine. He was also the vice chair of the department of medicine at the David Geffen School of Medicine at the University of California, Los Angeles.